CHA Biotech (085660) has 1 disclosed insider purchases and 5 disclosed disposals on record, filed by 5 distinct insiders. Together those filings cover ₩216M ($150K) in reported transaction value. The earliest filing StockDrifts holds for CHA Biotech is dated 2025-04-22; the most recent is 2026-06-25. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +16.40%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-06-25 | SELL | Market Sell | 윤보현 Bohyun Yoon | Managing Director | -1.0K | ₩10,930 | +4.3% | ₩11M ($8K) |
| 2026-06-04 | SELL | Market Sell | 장경호 Jang Kyung-ho | Managing Director | -500 | ₩12,830 | +5.0% | ₩6M ($4K) |
| 2026-05-01 | BUY | 신규선임 | 고정재 fixing material | torture | 12.5K | ₩16,900 | -19.7% | ₩211M ($147K) |
| 2026-03-31 | BUY | 주식매수선택권 | 양은영 Eunyoung Yang | vice president | 10.0K | ₩17,350 | +2.6% | ₩174M ($120K) |
| 2026-03-30 | SELL | Market Sell | 양은영 Eunyoung Yang | vice president | -2.0K | ₩18,400 | +3.3% | ₩37M ($26K) |
| 2026-03-27 | SELL | Market Sell | 양은영 Eunyoung Yang | vice president | -4.1K | ₩19,680 | +0.0% | ₩81M ($56K) |
| 2026-02-05 | SELL | Market Sell | 민영선 Min Young-seon | vice president | -2.8K | ₩21,550 | +1.4% | ₩59M ($41K) |
| 2025-07-28 | BUY | 신규선임 | 고경아 Go Kyeong-ah | Assistant Managing Director | 7.9K | ₩11,260 | +88.7% | ₩89M ($62K) |
| 2025-07-22 | BUY | Market Buy | 전태준 Taejun Jeon | Outside Director | 1.9K | ₩11,520 | +84.5% | ₩21M ($15K) |
| 2025-06-16 | SELL | 기타 | 정재석 Jaeseok Jeong | Managing Director | -341 | ₩10,680 | -99.0% | ₩4M ($3K) |
| 2025-06-16 | SELL | 기타 | 양승호 Seungho Yang | Managing Director | -341 | ₩10,680 | -99.0% | ₩4M ($3K) |
| 2025-06-16 | SELL | 기타 | 민영선 Min Young-seon | vice president | -683 | ₩10,680 | -99.0% | ₩7M ($5K) |
| 2025-06-16 | SELL | 기타 | 윤보현 Bohyun Yoon | Managing Director | -5.3K | ₩10,680 | -99.0% | ₩57M ($40K) |
| 2025-06-16 | SELL | 기타 | 이상규 Lee Sang-gyu | Internal director | -5.5K | ₩10,680 | -99.0% | ₩59M ($41K) |
| 2025-06-16 | SELL | 기타 | 양은영 Eunyoung Yang | vice president | -3.7K | ₩10,680 | -99.0% | ₩39M ($27K) |
| 2025-06-16 | SELL | 기타 | 박윤상 Park Yun-sang | Internal director | -5.5K | ₩10,680 | -99.0% | ₩59M ($41K) |
| 2025-06-16 | SELL | 기타 | 남수연 Sooyeon Nam | president | -30.0K | ₩10,680 | -99.0% | ₩320M ($223K) |
| 2025-06-16 | SELL | 기타 | 케이에이치그린 KH Green | - | -2.8M | ₩10,680 | -99.0% | ₩30.4B ($21.1M) |
| 2025-06-16 | SELL | 기타 | 이동준 Lee Dongjun | vice president | -5.7K | ₩10,680 | -99.0% | ₩61M ($42K) |
| 2025-06-16 | SELL | 기타 | 차광렬 Cha Gwang-ryeol | - | -622.4K | ₩10,680 | -99.0% | ₩6.6B ($4.6M) |
| 2025-06-16 | SELL | 기타 | 한기원 Korea Kiwon | president | -15.0K | ₩10,680 | -99.0% | ₩160M ($111K) |
| 2025-06-16 | SELL | 기타 | 나혜정 Na Hye-jeong | Managing Director | -2.2K | ₩10,680 | -99.0% | ₩23M ($16K) |
| 2025-06-16 | SELL | 기타 | 김민우 Minwoo Kim | Managing Director | -2.0K | ₩10,680 | -99.0% | ₩21M ($15K) |
| 2025-06-16 | SELL | 기타 | 이영진 Youngjin Lee | Managing Director | -2.0K | ₩10,680 | -99.0% | ₩21M ($15K) |
| 2025-06-16 | SELL | 기타 | 박번 Park number | president | -15.0K | ₩10,680 | -99.0% | ₩160M ($111K) |
| 2025-06-16 | SELL | 기타 | 최석윤 Choi Seok-yoon | Internal director (CEO) | -40.0K | ₩10,680 | -99.0% | ₩427M ($297K) |
| 2025-06-16 | SELL | 기타 | 홍연주 Yeonju Hong | Managing Director | -8.0K | ₩10,680 | -99.0% | ₩85M ($59K) |
| 2025-06-16 | SELL | 기타 | 배동구 Baedong-gu | Managing Director | -2.0K | ₩10,680 | -99.0% | ₩21M ($15K) |
| 2025-06-16 | SELL | 기타 | 강재선 Kang Jae-seon | Managing Director | -1.2K | ₩10,680 | -99.0% | ₩13M ($9K) |
| 2025-06-16 | SELL | 기타 | 장경호 Jang Kyung-ho | Managing Director | -500 | ₩10,680 | -99.0% | ₩5M ($4K) |
| 2025-06-16 | BUY | PROGRAM | 장경호 Jang Kyung-ho | Managing Director | 500 | ₩10,680 | +99.0% | ₩5M ($4K) |
| 2025-06-16 | BUY | PROGRAM | 나혜정 Na Hye-jeong | Managing Director | 2.2K | ₩10,680 | +99.0% | ₩23M ($16K) |
| 2025-06-16 | BUY | PROGRAM | 김민우 Minwoo Kim | Managing Director | 2.0K | ₩10,680 | +99.0% | ₩21M ($15K) |
| 2025-06-16 | BUY | PROGRAM | 이영진 Youngjin Lee | Managing Director | 2.0K | ₩10,680 | +99.0% | ₩21M ($15K) |
| 2025-06-16 | BUY | PROGRAM | 박번 Park number | president | 16.7K | ₩10,680 | +99.0% | ₩178M ($124K) |
| 2025-06-16 | BUY | PROGRAM | 최석윤 Choi Seok-yoon | Internal director (CEO) | 44.5K | ₩10,680 | +99.0% | ₩475M ($330K) |
| 2025-06-16 | BUY | PROGRAM | 홍연주 Yeonju Hong | Managing Director | 8.0K | ₩10,680 | +99.0% | ₩85M ($59K) |
| 2025-06-16 | BUY | PROGRAM | 배동구 Baedong-gu | Managing Director | 2.0K | ₩10,680 | +99.0% | ₩21M ($15K) |
| 2025-06-16 | BUY | PROGRAM | 강재선 Kang Jae-seon | Managing Director | 1.3K | ₩10,680 | +99.0% | ₩14M ($10K) |
| 2025-06-16 | BUY | PROGRAM | 정재석 Jaeseok Jeong | Managing Director | 379 | ₩10,680 | +99.0% | ₩4M ($3K) |
| 2025-06-16 | BUY | PROGRAM | 양승호 Seungho Yang | Managing Director | 379 | ₩10,680 | +99.0% | ₩4M ($3K) |
| 2025-06-16 | BUY | PROGRAM | 민영선 Min Young-seon | vice president | 759 | ₩10,680 | +99.0% | ₩8M ($6K) |
| 2025-06-16 | BUY | PROGRAM | 윤보현 Bohyun Yoon | Managing Director | 5.3K | ₩10,680 | +99.0% | ₩57M ($40K) |
| 2025-06-16 | BUY | PROGRAM | 이상규 Lee Sang-gyu | Internal director | 6.1K | ₩10,680 | +99.0% | ₩65M ($45K) |
| 2025-06-16 | BUY | PROGRAM | 양은영 Eunyoung Yang | vice president | 4.1K | ₩10,680 | +99.0% | ₩44M ($30K) |
| 2025-06-16 | BUY | PROGRAM | 한기원 Korea Kiwon | president | 16.7K | ₩10,680 | +99.0% | ₩178M ($124K) |
| 2025-06-16 | BUY | PROGRAM | 박윤상 Park Yun-sang | Internal director | 5.5K | ₩10,680 | +99.0% | ₩59M ($41K) |
| 2025-06-16 | BUY | PROGRAM | 남수연 Sooyeon Nam | president | 33.4K | ₩10,680 | +99.0% | ₩356M ($248K) |
| 2025-06-16 | BUY | PROGRAM | 케이에이치그린 KH Green | - | 3.1M | ₩10,680 | +99.0% | ₩32.7B ($22.7M) |
| 2025-06-16 | BUY | PROGRAM | 이동준 Lee Dongjun | vice president | 5.7K | ₩10,680 | +99.0% | ₩61M ($42K) |
Showing the 50 most recent of 77 filings.
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for CHA Biotech. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.